Skip to main content

RedHill Biopharma Ltd.

RDHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553846

In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in RedHill Biopharma Ltd. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
12
+1 vs. Q4 2024
Shares held
30.3K
+13.6K (+81.4%) vs. Q4 2024
Total value
$80.5K
−$23.0K (−22.2%) vs. Q4 2024
New holders
2
3 more added
Sold out
1
3 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 12 institutions
Q1 2021: 64 institutionsQ2 2021: 55 institutionsQ3 2021: 61 institutionsQ4 2021: 57 institutionsQ1 2022: 49 institutionsQ2 2022: 48 institutionsQ3 2022: 43 institutionsQ4 2022: 41 institutionsQ1 2023: 20 institutionsQ2 2023: 21 institutionsQ3 2023: 19 institutionsQ4 2023: 19 institutionsQ1 2024: 17 institutionsQ2 2024: 18 institutionsQ3 2024: 11 institutionsQ4 2024: 11 institutionsQ1 2025: 12 institutionsQ2 2025: 12 institutionsQ3 2025: 14 institutionsQ4 2025: 17 institutionsQ1 2026: 16 institutionsQ2 2026: 14 institutions
Value heldQ1 2025: $80.5K
Q1 2021: $77.4MQ2 2021: $49.1MQ3 2021: $24.5MQ4 2021: $12.5MQ1 2022: $11.9MQ2 2022: $3.89MQ3 2022: $1.46MQ4 2022: $1.51MQ1 2023: $1.20MQ2 2023: $419.2KQ3 2023: $781.9KQ4 2023: $449.2KQ1 2024: $1.40MQ2 2024: $719.7KQ3 2024: $48.8KQ4 2024: $103.5KQ1 2025: $80.5KQ2 2025: $37.9KQ3 2025: $51.2KQ4 2025: $514.5KQ1 2026: $386.5KQ2 2026: $270.0K
Institutions holding RDHL and their total value by quarter
QuarterHoldersValue
Q2 202614$270.0K
Q1 202616$386.5K
Q4 202517$514.5K
Q3 202514$51.2K
Q2 202512$37.9K
Q1 202512$80.5K
Q4 202411$103.5K
Q3 202411$48.8K
Q2 202418$719.7K
Q1 202417$1.40M
Q4 202319$449.2K
Q3 202319$781.9K
Q2 202321$419.2K
Q1 202320$1.20M
Q4 202241$1.51M
Q3 202243$1.46M
Q2 202248$3.89M
Q1 202249$11.9M
Q4 202157$12.5M
Q3 202161$24.5M
Q2 202155$49.1M
Q1 202164$77.4M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q4 2024.

Institutions holding RDHL in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC21,512$57.2K0.00%+21,512New
GAMMA Investing LLC3,568$9.49K0.00%−1,521−29.9%Reduced
Federation des caisses Desjardins du Quebec3,388$9.01K0.00%00.0%Unchanged
Rhumbline Advisers1,388$3.69K0.00%+190+15.9%Added
Bank of America Corp303$8060.00%+301+15,050.0%Added
Financial Management Professionals, Inc.47$1250.00%+47New
Group One Trading, L.P.22$590.00%00.0%Unchanged
Morgan Stanley13$340.00%−2,200−99.4%Reduced
SBI Securities Co., Ltd.5$130.00%+3+150.0%Added
UBS Group AG3$80.00%−4,364−99.9%Reduced
Vermillion Wealth Management, Inc.2$50.00%00.0%Unchanged
Royal Bank of Canada4$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.0$00.00%−396−100.0%Sold out